Antimicrobial Agents Practice Questions

Q: A 55-year-old patient with disseminated tuberculosis is prescribed antitubercular drugs. Which of the following adverse effects might be seen in a patient receiving regular intramuscular injections of streptomycin?

Deafness. **Explanation:** Streptomycin is an **Aminoglycoside** antibiotic used as a first-line drug in the treatment of Tuberculosis (though its use is now limited due to the availability of oral alternatives). **1. Why Deafness is Correct:** Aminoglycosides are notorious for their **ototoxicity** and **nephrotoxicity**. Streptomycin specifically targets the 8th cranial nerve (Vestibulocochlear nerve). It accumulates in the endolymph and perilymph of the inner ear, leading to the destruction of sensory hair cells. While it is more commonly associated with **vestibular damage** (vertigo, ataxia), it also causes **cochlear damage**, resulting in permanent sensorineural hearing loss or deafness. **2. Why Incorrect Options are Wrong:** * **A. Blindness:** This is a classic side effect of **Ethambutol**, which causes optic neuritis (decreased visual acuity and red-green color blindness). * **B. Increased AST levels:** Hepatotoxicity (elevated liver enzymes) is a common side effect of **Isoniazid (INH), Rifampin, and Pyrazinamide**, but not Streptomycin. * **C. Impotence:** This is not a recognized side effect of any standard first-line antitubercular drugs. **Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Streptomycin inhibits bacterial protein synthesis by binding to the **30S ribosomal subunit**, causing mRNA misreading. * **Contraindication:** It is **teratogenic** (causes fetal ototoxicity) and is the only first-line ATT drug contraindicated in pregnancy. * **Excretion:** It is excreted unchanged by the kidneys; hence, dosage adjustment is vital in renal failure to prevent toxicity. * **Mnemonic for ATT Side Effects:** **E**thambutol (**E**ye), **S**treptomycin (**S**ound/Ears), **I**NH (**I**soniazid - **I**njures Nerves/Liver).

Q: Which of the following drugs is NOT commonly used against enteric fever?

Amikacin. **Explanation:** Enteric fever (Typhoid) is caused by *Salmonella typhi* and *S. paratyphi*, which are **intracellular** pathogens. Effective treatment requires drugs that can achieve high concentrations within cells and the biliary tract. **Why Amikacin is the correct answer:** Amikacin is an **Aminoglycoside**. Aminoglycosides are polar molecules that are poorly lipid-soluble; consequently, they have **poor intracellular penetration**. Furthermore, they are primarily effective against aerobic extracellular gram-negative bacilli and lack clinical efficacy against *Salmonella* species in the context of enteric fever. Therefore, they are not used in its management. **Why the other options are incorrect:** * **Ciprofloxacin (Fluoroquinolone):** Historically the drug of choice due to excellent intracellular penetration and high biliary concentration. However, its use is now limited in many regions due to rising Nalidixic acid resistance (NARST). * **Ceftriaxone (3rd Gen Cephalosporin):** Currently the **drug of choice** for empirical treatment of complicated or multidrug-resistant (MDR) enteric fever. It is administered parenterally. * **Azithromycin (Macrolide):** An excellent oral alternative for uncomplicated typhoid, especially in cases of fluoroquinolone resistance, due to its massive intracellular accumulation and long half-life. **High-Yield Clinical Pearls for NEET-PG:** 1. **Drug of Choice (Empirical):** Ceftriaxone. 2. **Best Oral Drug (for MDR strains):** Azithromycin. 3. **Carrier State:** The drug of choice to eradicate the chronic carrier state (in the gallbladder) is **Ciprofloxacin** (for 4–6 weeks) or Ampicillin. 4. **Historical Context:** Chloramphenicol was the first drug of choice but is now obsolete due to resistance and bone marrow toxicity.

Q: A pregnant patient at 20 weeks gestation presents with fever and dysuria, leading to a preliminary diagnosis of cystitis. Which of the following antibiotics is safe to use for this patient?

Amoxicillin. **Explanation:** **Correct Answer: D. Amoxicillin** **Why Amoxicillin is correct:** Amoxicillin is a penicillin-group antibiotic and is classified as **FDA Pregnancy Category B**. It is considered safe and effective for treating Urinary Tract Infections (UTIs) in pregnancy because it does not cross the placental barrier in harmful concentrations and lacks teratogenic potential. In pregnant patients, asymptomatic bacteriuria and cystitis must be treated promptly to prevent progression to pyelonephritis, which is associated with preterm labor. **Why the other options are incorrect:** * **A. Ciprofloxacin:** Fluoroquinolones are generally avoided in pregnancy (Category C) as they have a high affinity for bone and cartilage, potentially causing **arthropathy** and permanent cartilage damage in the developing fetus. * **B. Gentamicin:** Aminoglycosides are associated with **ototoxicity** (damage to the 8th cranial nerve) and potential nephrotoxicity in the fetus. They are reserved for life-threatening infections like severe pyelonephritis where no safer alternative exists. * **C. Cotrimoxazole:** This is a combination of Sulfamethoxazole and Trimethoprim. Trimethoprim is a **folate antagonist** (risk of neural tube defects in the 1st trimester), and Sulfonamides can displace bilirubin from albumin, leading to **kernicterus** in the newborn if used near term. **NEET-PG High-Yield Pearls:** * **Drug of Choice for UTI in Pregnancy:** Nitrofurantoin (avoided only at term/near labor due to risk of neonatal hemolysis) or Amoxicillin/Cephalosporins. * **Safe Antibiotics (Category B):** Penicillins, Cephalosporins, Erythromycin (except estolate form), and Azithromycin. * **Teratogenic mnemonic:** "**T**atty **C**ats **A**re **G**reedy" (**T**etracycline - stained teeth; **C**hloramphenicol - Gray baby syndrome; **A**minoglycosides - Ototoxicity; **G**luoroquinolones - Cartilage damage).

Q: Which protease inhibitor has a boosting effect?

Ritonavir. **Explanation:** **Ritonavir** is the correct answer because it is a potent inhibitor of the **Cytochrome P450 3A4 (CYP3A4)** enzyme. In HIV therapy, it is primarily used at low doses as a **pharmacokinetic enhancer (booster)** rather than for its own antiviral activity. By inhibiting the metabolism of other Protease Inhibitors (PIs) like Lopinavir or Darunavir, Ritonavir increases their plasma concentration, prolongs their half-life, and allows for less frequent dosing and improved efficacy. This strategy is known as "Ritonavir-boosted therapy." **Analysis of Incorrect Options:** * **Amprenavir:** This is a protease inhibitor, but it does not possess the significant enzyme-inhibitory properties required to boost other drugs. It is actually the drug that often *requires* boosting. * **Tenofovir:** This is a Nucleotide Reverse Transcriptase Inhibitor (NRTI), not a protease inhibitor. It works by inhibiting the viral reverse transcriptase enzyme. * **Nelfinavir:** This is the only protease inhibitor that is **not** significantly boosted by Ritonavir because it is primarily metabolized by CYP2C19 rather than CYP3A4. **High-Yield Clinical Pearls for NEET-PG:** * **Cobicistat:** Another non-antiviral drug used solely as a booster (pharmacokinetic enhancer) in HAART regimens. * **Adverse Effects of PIs:** Look for "Buffalo Hump" (lipodystrophy), hyperglycemia (insulin resistance), and hyperlipidemia in clinical vignettes. * **Drug Interactions:** Due to CYP3A4 inhibition, Ritonavir has numerous drug-drug interactions (e.g., it can lead to toxicity of statins or benzodiazepines).

Q: Isolated hyperbilirubinemia is classically seen as an adverse effect of which medication?

Rifampin. **Explanation:** **Correct Option: B (Rifampin)** Rifampin is known to cause **isolated hyperbilirubinemia** (predominantly unconjugated) because it competes with bilirubin for uptake into hepatocytes and interferes with its excretion into the bile. Unlike other hepatotoxic drugs, this effect is often transient and occurs without an elevation in serum transaminases (ALT/AST). It is a dose-dependent, pharmacological interference rather than true hepatocellular injury. **Analysis of Incorrect Options:** * **A. Isoniazid (INH):** While INH is hepatotoxic, it typically causes a **hepatocellular pattern** of injury characterized by significant elevations in ALT and AST. It does not cause isolated hyperbilirubinemia. * **C. Pyrazinamide:** This is the most hepatotoxic drug among the first-line ATT. It causes severe liver injury and can trigger gouty arthritis by inhibiting urate excretion, but it does not present with isolated bilirubin elevation. * **D. Capreomycin:** This is a second-line injectable agent (cyclic peptide). Its primary adverse effects are **nephrotoxicity** and **ototoxicity** (similar to aminoglycosides), not hepatotoxicity. **NEET-PG High-Yield Pearls:** * **Rifampin:** Potent inducer of Cytochrome P450 enzymes; causes orange-red discoloration of body fluids (urine, sweat, tears). * **Hepatotoxicity Profile:** Pyrazinamide > Isoniazid > Rifampin (P > I > R). * **Visual Side Effects:** Ethambutol causes optic neuritis (red-green color blindness). * **Clinical Rule:** If a patient on ATT develops jaundice with AST/ALT levels <3 times the upper limit of normal, Rifampin-induced competition for bilirubin uptake is the likely cause.

Q: Which of the following is NOT considered a broad-spectrum antibiotic?

Penicillin G. **Explanation:** The classification of antibiotics is based on their **spectrum of activity**, which refers to the range of microorganisms they can effectively inhibit. **1. Why Penicillin G is the correct answer:** Penicillin G (Benzylpenicillin) is a **narrow-spectrum antibiotic**. It is primarily effective against Gram-positive cocci (e.g., *Streptococci*), some Gram-positive bacilli, and certain Gram-negative cocci (e.g., *Neisseria*). It is highly susceptible to inactivation by beta-lactamases and lacks significant activity against most Gram-negative rods. **2. Why the other options are incorrect:** * **Tetracycline & Doxycycline (Options A & C):** These belong to the Tetracycline class, which are classic **broad-spectrum** agents. They inhibit protein synthesis (30S subunit) and are effective against a wide array of Gram-positive and Gram-negative bacteria, as well as atypical organisms like *Rickettsia*, *Chlamydia*, and *Mycoplasma*. * **Chloramphenicol (Option B):** This is a potent **broad-spectrum** antibiotic that inhibits the 50S ribosomal subunit. It covers a vast range of aerobic and anaerobic bacteria, though its use is limited due to toxicity (e.g., Bone marrow suppression, Gray Baby Syndrome). **High-Yield NEET-PG Pearls:** * **Broad-spectrum definition:** Antibiotics that act on both Gram-positive and Gram-negative bacteria, often including anaerobes or atypicals. * **Extended-spectrum:** This term is often applied to semi-synthetic penicillins like **Amoxicillin** or **Piperacillin**, which have a broader range than Penicillin G but are narrower than Tetracyclines. * **Drug of Choice:** Penicillin G remains the drug of choice for **Syphilis** (*Treponema pallidum*). * **Resistance:** Most *Staphylococci* are now resistant to Penicillin G due to penicillinase production.

Q: Which of the following statements about vancomycin is NOT true?

It acts by inhibiting bacterial protein synthesis.. **Explanation** **1. Why Option B is the Correct Answer (The False Statement):** Vancomycin does **not** inhibit protein synthesis. Instead, it is a **cell wall synthesis inhibitor**. It acts by binding firmly to the **D-Ala-D-Ala** terminus of the nascent peptidoglycan pentapeptide. This binding sterically hinders transglycosylation and transpeptidation, preventing the cross-linking of the peptidoglycan layer. In contrast, protein synthesis inhibitors typically target the 30S or 50S ribosomal subunits (e.g., Aminoglycosides, Macrolides). **2. Analysis of Other Options:** * **Option A:** Vancomycin is indeed **bactericidal** (except against Enterococci, where it is bacteriostatic) and has a narrow spectrum limited to **Gram-positive** organisms (MRSA, *S. epidermidis*, *C. difficile*). Its large molecular size prevents it from crossing the outer membrane of Gram-negative bacteria. * **Option C:** It is a standard alternative for patients allergic to penicillin in cases of **Enterococcal endocarditis**, usually used in combination with an aminoglycoside for synergy. * **Option D:** **Ototoxicity** (deafness) and nephrotoxicity are well-known dose-related adverse effects, especially when vancomycin is administered with other ototoxic drugs like furosemide or gentamicin. **High-Yield Clinical Pearls for NEET-PG:** * **Red Man Syndrome:** A common infusion-related reaction caused by histamine release (not an allergy). Prevented by slowing the infusion rate. * **Drug of Choice:** For **MRSA** and orally for **Pseudomembranous colitis** (*C. difficile*). * **Resistance Mechanism:** Alteration of the binding site from D-Ala-D-Ala to **D-Ala-D-Lac** (seen in VRSA/VRE). * **Excretion:** Primarily renal; requires dose adjustment in renal failure.

Question 1

A 55-year-old patient with disseminated tuberculosis is prescribed antitubercular drugs. Which of the following adverse effects might be seen in a patient receiving regular intramuscular injections of streptomycin?

Accepted Answer

Deafness

Answer

Blindness

Answer

Increased AST levels

Answer

Impotence

Question 2

Which of the following drugs is NOT commonly used against enteric fever?

Accepted Answer

Amikacin

Answer

Ciprofloxacin

Answer

Ceftriaxone

Answer

Azithromycin

Question 3

An 82-year-old hospitalized patient with creatinine clearance of 25 mL/min has a microbial infection requiring treatment with antibiotics. Which one of the following drugs is least likely to require a dosage adjustment, either a smaller dose than usual or an increased interval between doses?

Accepted Answer

Erythromycin

Answer

Amphotericin B

Answer

Gentamicin

Answer

Imipenem-cilastatin

Question 4

A pregnant patient at 20 weeks gestation presents with fever and dysuria, leading to a preliminary diagnosis of cystitis. Which of the following antibiotics is safe to use for this patient?

Accepted Answer

Amoxicillin

Answer

Ciprofloxacin

Answer

Gentamicin

Answer

Cotrimoxazole

Question 5

What is the most serious adverse effect of ketoconazole?

Accepted Answer

Adrenal insufficiency

Answer

Pellagra-like skin lesion

Answer

Liver injury

Answer

Prostate cancer

Question 6

Which protease inhibitor has a boosting effect?

Accepted Answer

Ritonavir

Answer

Amprenavir

Answer

Tenofovir

Answer

Nelfinavir

Question 7

Isolated hyperbilirubinemia is classically seen as an adverse effect of which medication?

Accepted Answer

Rifampin

Answer

Isoniazid (INH)

Answer

Pyrazinamide

Answer

Capreomycin

Question 8

Which of the following is NOT considered a broad-spectrum antibiotic?

Accepted Answer

Penicillin G

Answer

Tetracycline

Answer

Chloramphenicol

Answer

Doxycycline

Question 9

Which among the following is not a beta-lactamase resistant Penicillin?

Accepted Answer

Carbenicillin

Answer

Methicillin

Answer

Nafcillin

Answer

Oxacillin

Question 10

Which of the following statements about vancomycin is NOT true?

Accepted Answer

It acts by inhibiting bacterial protein synthesis.

Answer

It is a bactericidal antibiotic active primarily against gram-positive bacteria.

Answer

It is an alternative to penicillin for enterococcal endocarditis.

Answer

It can cause deafness as a dose-related toxicity.

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?